News

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
FDA to limit COVID-19 boosters for 'low risk' people under 65. What to know in Tennessee
Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
USA Today2d
Changes are happening around COVID-19 vaccines: Here's what to know
COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual ...
PhillyVoice4d
New FDA restrictions will make COVID-19 vaccines only available to elderly and people with medical conditions
Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.
Phoenix doctor weighs in on possible limited access to COVID-19 shots
A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...